Evidence map›Paper›PMID 29761007›Full record

ArticleBrain and behavior2018

Behavioral changes induced through adenosine A2A receptor ligands in a rat depression model induced by olfactory bulbectomy.

Karla Margarita Padilla, Andres Quintanar-Setephano, Fabian López-Vallejo, Laura Cristina Berumen, Ricardo Miledi, Guadalupe García-Alcocer

Open access · goldAbstract read
In one paragraph

Article in Brain and behavior, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.5field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 40 citations in OpenAlex.

  1. Article
  2. GPCRs: emerging targets for novel T cell immune checkpoint therapy.Cancer immunology, immunotherapy : CII · 2024
    Review
  3. Adenosine and adenosine receptors in metabolic imbalance-related neurological issues.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2024
    Review
  4. Article
  5. Lateral septum adenosine ANature communications · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Adenosine AFrontiers in neuroscience · 2021
    Review
  11. Role of Adenosine in Epilepsy and Seizures.Journal of caffeine and adenosine research · 2020
    Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Karla Margarita PadillaFacultad de Química Universidad Autónoma de Querétaro Centro Universitario Querétaro México.
Andres Quintanar-SetephanoCentro de Ciencias Básicas Departamento de Fisiología y Farmacología Universidad Autónoma de Aguascalientes Aguascalientes México.
Fabian López-VallejoFacultad de Ciencias Departamento de Química Universidad Nacional de Colombia Bogotá Colombia.
Laura Cristina BerumenFacultad de Química Universidad Autónoma de Querétaro Centro Universitario Querétaro México.
Ricardo MilediInstituto de Neurobiología Universidad Nacional Autónoma de México Juriquilla Querétaro México.
Guadalupe García-AlcocerFacultad de Química Universidad Autónoma de Querétaro Centro Universitario Querétaro México.ORCID 0000-0002-7768-344X
Autonomous University of Queretaro · MXAutonomous University of Aguascalientes · MXUniversidad Nacional Autónoma de México · MXUniversidad Nacional de Colombia · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Major depressive disorders are characterized by their severity and long-lasting symptoms, which make such disorders highly disabling illnesses. Unfortunately, 50% of major depressive patients experience relapses, perhaps partly because drug research has been performed only in animal models that screen for antidepressant drugs that appear to only ameliorate acute depression symptoms. The bilateral olfactory bulbectomy (OBX) animal model presents the advantage of mimicking the symptoms of chronic depression by means of brain surgery. Adenosine purinergic receptors A2A (A2AR) have been the target of interest in the field of psychiatric diseases. This study aimed to show which A2A receptor ligands exert antidepressive-like effects in the OBX rat model. Methods: Forty Sprague-Dawley male rats were divided into four groups: control, OBX + vehicle, OBX + ZM 241385, and OBX + adenosine groups. Pharmacological treatment was administered for 14 days, and the rats were examined via the forced swim test (FST), open field test (OFT), and sucrose preference test (SPT). Results: The OBX + ZM 241385 group exhibited decreased immobility time in the FST, decreased isolation time in the OFT, and reversed anhedonia behavior in the SPT compared to the vehicle group. However, no significant differences for adenosine treatment were found. Conclusions: ZM 241385 administration (2 mg/kg i.p.) restored behavioral changes associated with OBX-induced depression.

Indexed as

Disease Models, AnimalMajor Depressive DisorderAdenosineAnhedoniaAnimalsAntidepressive AgentsBehavior, AnimalLigandsMaleOlfactory BulbPurinergic P1 Receptor AgonistsRatsRats, Sprague-DawleyReceptor, Adenosine A2ATreatment OutcomeAdenosineAntidepressive AgentsLigandsPurinergic P1 Receptor AgonistsReceptor, Adenosine A2AA2A receptorsadenosinebehavioral testsmajor depressive disorderZM 241385

Identifiers

PMID29761007
PMCPMC5943772
OpenAlexW2800199224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.